stock quote

ENDP (Common Stock)

Exchange

NASDAQ (US Dollar)

Price

$12.90

Change (%)

-0.27 (2.05%)

Volume

2,615,461

Minimum 20 minute delay




press release

For a complete list of press releases, Click Here


state disclosures

California Transparency In Supply Chains Act Disclosure. Click Here.


featured product


See Full Prescribing Information



Par - People Achieving Results

Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par offers differentiated, specialty dosage and sterile injectable drug products and is advancing a R&D pipeline of potential new products.

The recent combination of the Qualitest and Par businesses (known collectively as Par Pharmaceutical) expands Endo's generics business to a top five industry leader. Par Pharmaceutical is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENDP), a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Learn more at www.endo.com

quality you can depend on

High-quality and cost-effective products with the highest level of customer service.

facilities & manufacturing

Learn more about our state of the art facilities, distribution center, and our manufacturing & packaging capabilities.

our generics products

We offer an extensive range of prescription and over-the-counter products across a wide range of therapeutic areas.